Market Place
Sourcing Support
BMO says Lilly is pulling ahead of Novo in obesity market battle
18 Apr 2025 //
FIERCE PHARMA
OpenFold AI Research Consortium Welcomes New Members
15 Apr 2025 //
BUSINESSWIRE
Novo Nordisk warns of counterfeit Ozempic in US
14 Apr 2025 //
REUTERS
Novo charts $1B-plus Brazilian production expansion for GLP-1s
09 Apr 2025 //
FIERCE PHARMA
Novo Nordisk readies to bring weight-loss drug Wegovy to India
07 Apr 2025 //
ECONOMICTIMES
Novo`s longtime commercial strategy head hangs up gloves
04 Apr 2025 //
FIERCE PHARMA
Novo Nordisk announces changes in Executive Management
03 Apr 2025 //
GLOBENEWSWIRE
Novo`s longtime commercial strategy head hangs up the gloves
03 Apr 2025 //
FIERCE PHARMA
Novo nearly doubles earnings as Wegovy swells coffers
03 Apr 2025 //
REUTERS
SCORE analysis show semaglutide 2.4 mg reduce cardiovascular events
30 Mar 2025 //
PR NEWSWIRE
Ozempic® 1 mg improves outcomes in type 2 diabetes & PAD at Meeting
29 Mar 2025 //
PR NEWSWIRE
Novo Nordisk: Rybelsus shows superior cardiovascular event reduct
29 Mar 2025 //
GLOBENEWSWIRE
Novo to license obesity drug from Lexicon in up to $1 B deal
29 Mar 2025 //
FIERCE BIOTECH
Resolutions from the Annual General Meeting of Novo Nordisk A/S
27 Mar 2025 //
GLOBENEWSWIRE
Novo Holdings joins €23M Series A for Tribune Therapeutics
26 Mar 2025 //
PR NEWSWIRE
MUHC Foundation gets $2M for Metabolic Centre of Excellence
25 Mar 2025 //
GLOBENEWSWIRE
Novo offers cheaper Wegovy for all cash-paying patients
25 Mar 2025 //
FIERCE PHARMA
Novo licenses China-based biotech`s drug for up to $2B
25 Mar 2025 //
REUTERS
United Labs, Novo Nordisk agree on UBT251 license deal
24 Mar 2025 //
GLOBENEWSWIRE
Not a cost-cutting exercise`: Novo reshapes R&D setup
21 Mar 2025 //
FIERCE BIOTECH
Novo presents new semaglutide data at ACC 74th Scientific Sessions
17 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Foundation Project Sparks Ultra-Processed Food Debate
12 Mar 2025 //
REUTERS
FDA to hold off action on weight-loss drug copies pending court ruling
11 Mar 2025 //
REUTERS
Novo’s CagriSema Shows Superior Weight Loss In Redefine 2 Trial
10 Mar 2025 //
GLOBENEWSWIRE
Novo trial with next-gen diabetes drug shows 15.7% weight loss
10 Mar 2025 //
REUTERS
Novo to sell Wegovy for $499 a month to cash-paying US customers
06 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Launches "My Ozempic Era" Campaign For Patients
03 Mar 2025 //
PR NEWSWIRE
Gensaic, Novo Nordisk Partner on Next-Gen Precision Therapies
03 Mar 2025 //
BUSINESSWIRE
Novo Nordisk A/S: Annual General Meeting Notice
27 Feb 2025 //
GLOBENEWSWIRE
Novo`s Wegovy and Ozempic removed from US FDA shortage list
22 Feb 2025 //
REUTERS
FDA Confirms Wegovy & Ozempic Shortage Over, Novo Meets Demand
21 Feb 2025 //
PR NEWSWIRE
Novo alleges fraud after $1.3 B deal to buy drug from KBP Biosciences
19 Feb 2025 //
FIERCE BIOTECH
Novo Nordisk calls out dangers of compounded GLP-1s in new ad
12 Feb 2025 //
FIERCE PHARMA
Novo’s Bispecific for Hemophilia Aces Phase III Pediatric Trial
08 Feb 2025 //
BIOSPACE
Novo Nordisk Board, Executives Trade Company Shares
07 Feb 2025 //
GLOBENEWSWIRE
Trading in Novo shares by board members, executives associated persons
06 Feb 2025 //
GLOBENEWSWIRE
Novo fails trial, linking obesity asset to psychiatric effects
06 Feb 2025 //
FIERCE BIOTECH
Novo Nordisk Says Trump Tariffs May Have Limited Business Impact
05 Feb 2025 //
REUTERS
Novo defends next-gen obesity drug CagriSema, details new trial
05 Feb 2025 //
REUTERS
Novo Nordisk Sales Increased by 25% in 2024 to DKK 290.4 Billion
05 Feb 2025 //
GLOBENEWSWIRE
Novo Nordisk files annual report with the SEC
05 Feb 2025 //
GLOBENEWSWIRE
Wegovy maker Novo says surging growth driving emissions higher
05 Feb 2025 //
REUTERS
Novo Nordisk A/S - share repurchase programme
04 Feb 2025 //
GLOBENEWSWIRE
Investors answers on Novo Nordisk`s next-gen obesity drug CagriSema
03 Feb 2025 //
REUTERS
Novo Nordisk To Test CagriSema`s Long-Term Efficacy In Trial
31 Jan 2025 //
REUTERS
FDA approves Novo`s Ozempic to cut risk of diabetic kidney disease
29 Jan 2025 //
PRESS RELEASE
Veru`s drug helps older obese patients on Wegovy preserve muscle
28 Jan 2025 //
REUTERS
Novo to cap insulin prices in settlement; joins Lilly, Sanofi
28 Jan 2025 //
REUTERS
Novo Nordisk A/S - share repurchase programme
27 Jan 2025 //
GLOBENEWSWIRE
Moderna, Novo slammed for breaching UK drug marketing code again
27 Jan 2025 //
FIERCE PHARMA
Novo`s amycretin prompts 22% weight loss in early obesity trial
25 Jan 2025 //
ENDPTS
Novo inks IMMvention deal to orchestrate attack on sickle cell
23 Jan 2025 //
GLOBENEWSWIRE
Study of Novo, Lilly weight loss drugs show decrease in Alzheimer`s
22 Jan 2025 //
FIERCE PHARMA
Novo Nordisk A/S - share repurchase programme
20 Jan 2025 //
GLOBENEWSWIRE
Novo touts weight loss results in high-dose Wegovy study
18 Jan 2025 //
FIERCE PHARMA
Novo`s Ozempic, Wegovy picked for US Medicare price negotiations
18 Jan 2025 //
REUTERS
Novo Nordisk: Semaglutide Shows 20.7% Weight Loss In Step up Trial
17 Jan 2025 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
13 Jan 2025 //
GLOBENEWSWIRE
Novo Invests $200M for Windward Bio`s Asthma and COPD Treatments
10 Jan 2025 //
PR NEWSWIRE
Novo Puts $4.6B on the Line to Expand Valo Deal
09 Jan 2025 //
BIOSPACE
